NYSE:PFE - New York Stock Exchange, Inc. - US7170811035 - Common Stock - Currency: USD
Taking everything into account, PFE scores 5 out of 10 in our fundamental rating. PFE was compared to 197 industry peers in the Pharmaceuticals industry. While PFE has a great profitability rating, there are some minor concerns on its financial health. PFE is cheap, but on the other hand it scores bad on growth. PFE also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.76% | ||
ROE | 9.11% | ||
ROIC | 7.42% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 25.61% | ||
PM (TTM) | 12.62% | ||
GM | 74.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.69 | ||
Debt/FCF | 6.54 | ||
Altman-Z | 1.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.17 | ||
Quick Ratio | 0.92 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.12 | ||
Fwd PE | 7.41 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 12.77 | ||
EV/EBITDA | 6.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.97% |
22.14
+0.1 (+0.45%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.97% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.12 | ||
Fwd PE | 7.41 | ||
P/S | 1.97 | ||
P/FCF | 12.77 | ||
P/OCF | 9.85 | ||
P/B | 1.42 | ||
P/tB | N/A | ||
EV/EBITDA | 6.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.76% | ||
ROE | 9.11% | ||
ROCE | 9.56% | ||
ROIC | 7.42% | ||
ROICexc | 8.41% | ||
ROICexgc | 44.11% | ||
OM | 25.61% | ||
PM (TTM) | 12.62% | ||
GM | 74.19% | ||
FCFM | 15.46% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.69 | ||
Debt/FCF | 6.54 | ||
Debt/EBITDA | 2.6 | ||
Cap/Depr | 41.48% | ||
Cap/Sales | 4.57% | ||
Interest Coverage | 5.05 | ||
Cash Conversion | 54.68% | ||
Profit Quality | 122.46% | ||
Current Ratio | 1.17 | ||
Quick Ratio | 0.92 | ||
Altman-Z | 1.96 |